
Loading, please wait...

Loading, please wait...

Researchers recently introduced a revolutionary tool called the multi-tiered µDicer to improve spatial proteomic workflows. Mapping protein distribution within heterogeneous tissues requires high-resolution microdissection. While laser capture microdissection (LCM) remains the gold standard, it often faces limitations at the cellular scale.
Traditional LCM relies on lasers that can cause photothermal damage to delicate proteins. Furthermore, capturing microtissues below 20 µm often results in significant material loss. The multi-tiered µDicer addresses these issues through a mechanical approach. Specifically, it uses a hierarchical blade architecture fabricated by two-photon polymerization. This design lowers the cutting force by limiting instantaneous blade-tissue engagement. Consequently, it maintains tissue integrity even at a 10 µm resolution.
In benchmarking tests using human squamous cell carcinoma, the µDicer outperformed traditional LCM. Researchers analyzed these microtissues using nanoPOTS and liquid chromatography-mass spectrometry. The results showed that µDicers yielded significantly more peptides and proteins. Notably, the largest performance gains occurred at the 10-20 µm spatial resolution range.
Moreover, confocal imaging revealed that LCM creates catapult-associated cavities. These cavities lead to material loss and membrane-limited protein extraction. In contrast, the µDicer ensures reproducible microdissection while maintaining high protein coverage. Therefore, this technology offers a robust alternative for advanced molecular profiling.
The development of spatial registration for microtissues is currently underway. This progress will likely position µDicers as a vital complement to LCM. By enabling precise protein preservation, this tool will enhance our understanding of tumor heterogeneity and support personalized medicine strategies.
Unlike LCM, which uses heat-generating lasers, the µDicer employs mechanical blades. This avoids photothermal damage and prevents the material loss often seen during the laser catapulting process.
A 10 µm resolution corresponds to cellular dimensions. Achieving this precision allows researchers to study individual cell types within a tumor, providing a clearer picture of tissue heterogeneity.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or endorsement of any specific technology. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new multi-tiered µDicer device achieves 10 µm microdissection resolution with superior protein preservation for next-generation spatial proteomic workflow...
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today